相关实验视频

Updated: Jun 14, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

在急性性缺血性中风中,超过4.5小时的太尼克:随机临床试验的系统审查和元分析

Mohammad Aladawi¹, Mohammad T Abuawwad², Mohammad J J Taha²

¹Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.

Journal of stroke

|June 10, 2025

概括

甲 (TNK) 可能改善急性缺血性中风 (AIS) 患者的功能独立性,超过4.5小时. 这次元分析发现TNK是安全的,在延长4.5至24小时的窗口中没有增加出血或死亡风险.

科学领域:

神经学神经学
心血管医学心血管医学
药理学药理学是指药理学的学科.

背景情况:

急性缺血性中风 (AIS) 是全球残疾的主要原因之一.
目前的治疗指导方针建议静脉输血栓溶解在最后一个已知的时间 (LKW) 后4.5小时内进行.
许多AIS患者出现在治疗窗口之外.

研究的目的:

评估TNK在AIS患者的疗效和安全性,AIS患者的LKW在4.5至24小时之间.
为了评估功能独立性和顺序修改的兰金表 (mRS) 转移90天.
分析安全结果,包括症状性内出血 (sICH) 和死亡率.

主要方法:

随机对照试验 (RCT) 的系统审查和元分析.
包括的研究重点是针对AIS患者在LKW后4.5至24小时内给予TNK.
主要结局:功能独立 (mRS 0-2) 和顺序 mRS 转移. 安全结果:病态和死亡率.

主要成果:

在90天后,TNK治疗与实现功能独立 (mRS 0-2) 的可能性增加了33% (OR: 1.33,P=0.023).
在顺序式mRS转移 (SMD:0.01,P=0.09) 中没有观察到显著差异.
在sICH (OR:2.07,P=0.1) 或90天死亡率 (OR:1.08,P=0.67) 中没有发现显著差异.

结论:

在4.5至24小时窗口内出现的被选中的AIS患者中,基 (TNK) 可能提供改善的功能结果.
在这种延长的时间范围内,TNK似乎是安全的,没有显著增加出血并发症或死亡率.
进一步的研究可能会完善扩展窗口血栓溶解的患者选择.

关键词:

急性缺血性中风是一次急性缺血性中风.延长治疗窗口的时间.在静脉内进行血栓溶解.太尼克特代替了太尼克特.

更多相关视频

Prehospital Thrombolysis: A Manual from Berlin

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

相关概念视频

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...